Results of two phase 2 studies suggest efgartigimod could be a potential treatment for myositis and Sjögren disease in ...

The Launch-HTN trial is the largest trial of an aldosterone synthase inhibitor completed in participants with uncontrolled or treatment resistant hypertension – – Lorundrostat 50 mg once daily ...

Clinical safety : Data from two human Phase 3 studies in Alzheimer's disease demonstrated a favorable safety profile. “My research and collaboration ... a favorable clinical safety profile. Brief ...

Alongside her husband, Bob Duggan, Maky Zanganeh has guided cancer drug developer Summit Therapeutics to reach staggering new ...

I ran four miles every day, did breathing exercises, listened to a meditation tape a friend gave me. Useless. I finally caved and saw my general practitioner, who prescribed Ambien, telling me to feel ...

This study investigates the impact of personalized AI-generated video advertisements on consumer click-through rates (CTR), aiming to understand the effectiveness of personalized content in the ...

The cost of a bad hire can be devastating for a small business. This is the story of my biggest hiring disaster and the red flags I wish I'd recognized earlier.